LEP and gestational diabetes: Gestational diabetes-related immune dysregulation has been shown to lead to increased maternal IL-6 with enhanced placental leptin production but a paradoxical reduction in the IL-6 levels of the LGA offspring (30), possibly related to the hyperleptinemia that is typically seen in LGA infants (29).